We are doing this study to learn if the MMprofiler test can help your doctor in making decisions about your treatment. The MMprofiler genomic test will look at a large number of normal genes. The test will predict risk of your multiple myeloma by assessing whether these genes are turned on or off in your cancer cells. The purpose of this research is to study whether this test can help your doctor to determine what treatment will be best for your multiple myeloma.
As part of your normal medical care, your doctors will take a bone marrow sample. A small piece of this bone marrow sample will be used for the MMprofiler test.
If you agree to participate in this study no additional examinations, blood tests, or x-rays will be performed above and beyond your regular medical care.
Your doctor will be asked to complete a questionnaire about his/her treatment intention for you before he or she receives the MMprofiler result and after he or she receives the MMprofiler result.
The results of MMprofiler and the questionnaires will be stored in a database with additional medical information about you and your multiple myeloma. This includes, but is not limited to, your age, race/ethnicity, other diagnostic tests, your treatment and the response to your treatment. No personal information will be stored in the database, but there will be a code that links your identity to your data. Data will be collected at five (5) different time points:
Taking part in this study may or may not make your health better. However, the knowledge gained from this research may benefit future patients with multiple myeloma.
The following criteria is a partial list of reasons why patients may or may not be eligible to participate in this clinical trial. Further evaluation with a medical professional will be required to determine full eligibility.
The following criteria is provided for health care professionals.
The following is a listing of trial locations that are open and accepting patients.
The following is a listing of trial locations that are not currently open and accepting patients.
There are no resources, links or videos to display for this clinical trial.